Nasdaq 100 Stocks SEC Filings — March 23, 2026

23-03-2026

Faraday Future Intelligent Electric Inc. announced that the SEC has concluded its years-long investigation into 2021 PIPE and SPAC-related transactions with no enforcement action against the Company, founder and Co-CEO YT Jia, President Jerry Wang, or other team members, removing a major regulatory overhang. This provides clarity to pursue strategic financing, partnerships, Nasdaq compliance within 180 days without a reverse split, and focus on EAI vehicles and robotics. However, forward-looking statements highlight ongoing risks including liquidity shortages, potential delisting if share price falls below $0.10 for 10 days, substantial dilution needs, and execution challenges on vehicle deliveries and robotics.

• ·Nasdaq compliance notice received March 20, 2026, granting 180-day period to meet $1 minimum bid price without reverse stock split.
• ·SEC investigation originated from independent director probe in October 2021 related to SPAC merger.
• ·FF 91 deliveries began in 2023; Super One deliveries planned for 2026; Embodied AI Robotics sales beginning in 2026.

23-03-2026

Richmond Mutual Bancorporation, Inc. (RMBI) and The Farmers Bancorp, Frankfort, Indiana entered into a merger agreement on November 11, 2025, pursuant to which Farmers Bancorp will merge into RMBI, creating a combined bank holding company with approximately $2.6B in total assets and 25 branches across Indiana and Ohio. Farmers Bancorp shareholders will receive 3.40 shares of RMBI common stock per share (exchange ratio), valued at approximately $44.71 per share or $82.4M aggregate based on RMBI's closing price on the announcement date, with former Farmers shareholders owning ~38% of the combined company post-merger. The transaction is subject to shareholder approval at meetings in 2026 and includes standard risks such as potential changes in RMBI stock value.

• ·Merger agreement dated November 11, 2025; S-4 filing date March 23, 2026.
• ·RMBI trades on NASDAQ under 'RMBI'; Farmers Bancorp on OTC Pink under 'FABP'.
• ·Merger expected to qualify as tax-free reorganization under IRC Section 368(a), except for cash in lieu of fractional shares.
• ·Shareholder meetings: RMBI annual meeting and Farmers Bancorp special meeting scheduled for [·], 2026.
• ·I.R.S. Employer Identification No. for RMBI: 36-4926041.

23-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 23, 2026, announcing the issuance of a press release regarding the integration of RAD devices into the Immix platform by AITX's RAD and Immix entities. No financial metrics, performance comparisons, or quantitative impacts were disclosed in the filing.

23-03-2026

Technology & Telecommunication Acquisition Corp (TETE) has filed a DEFM14A proxy statement dated March 23, 2026, for an extraordinary general meeting on or after the record date of February 25, 2026, to approve a Business Combination with Super Apps and Holdings, resulting in PubCo listing on Nasdaq as RADB, subject to approval. Post-merger ownership remains stable across minimum, mid-point, and maximum redemption scenarios, with Holdings shareholders at 85.3-85.4% (basic) or 58.4% (fully diluted), Sponsor at 10.7%/9.3%, and public shareholders at a low 1.6-1.7%/29.7%; a $5.0M PIPE is committed (with $16.0M interest), but the trust account holds only $142,275.91 as of February 23, 2026, signaling potentially high redemptions. The merger will make PubCo a controlled company with Bradbury Private Investment XVIII holding 34.5% voting power, and includes Sponsor forfeitures of 447,952 shares and contingent shares to MobilityOne.

• ·Non-Redemption Agreements dated January 19, 2025 (150,000 shares forfeited) and April 14, 2025 (297,952 shares forfeited), terminated but forfeiture obligation survives.
• ·TETE incorporated November 8, 2021; Class A shares, warrants, units listed on OTC Pink Current January 23, 2025 under TETEF, TETWF, TETUF.
• ·Nasdaq listing approval for RADB is a closing condition, waivable by Holdings and Super Apps.
• ·Shareholder meeting requests for additional documents by March 19, 2026.

23-03-2026

AParadise Acquisition Corp., a SPAC listed on Nasdaq (APADU, APAD, APADR), released its PFIC Annual Information Statement for fiscal year 2025 (Jan 1 to Dec 31, 2025) on March 23, 2026, reporting per-share per-day ordinary earnings of $0.000605 and no net capital gains or distributions. The statement assists US shareholders with potential QEF elections under IRC Section 1295 and confirms the company may be treated as a PFIC. No other financial metrics or period comparisons were provided.

• ·Company incorporated November 9, 2022 in British Virgin Islands.
• ·Taxpayer Identification Number: N/A.
• ·Principal address: The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong.
• ·Emerging growth company: Yes.

23-03-2026

Comtech Telecommunications Corp. filed a Form S-3 shelf registration statement with the SEC on March 23, 2026, enabling the potential offering of up to $125 million in common stock, preferred stock, debt securities, warrants, purchase contracts, or units from time to time based on market conditions. The company's common stock (CMTL) had a last reported sale price of $3.66 per share on March 17, 2026, and trades on the Nasdaq Global Select Market. As a smaller reporting company, Comtech qualifies due to non-affiliate market value under $250M or annual revenue under $100M, allowing reduced disclosure obligations.

• ·Principal executive offices: 305 N 54th Street, Chandler, Arizona 85226; Phone: (480) 333-2200
• ·Incorporated in Delaware; I.R.S. Employer Identification Number: 11-2139466; Founded: 1967
• ·Reportable segments: Allerium (formerly Terrestrial and Wireless Networks) and Satellite and Space Communications

23-03-2026

Imunon, Inc. filed a prospectus supplement on March 23, 2026, to register an additional $7M of common stock shares issuable under its At the Market Offering Agreement with H.C. Wainwright & Co., LLC, increasing the total registered amount from $10M to $17M. As of the filing, the company had already sold $4.8M worth of shares through this agreement, which may result in shareholder dilution.

• ·Opinion regarding legality of shares filed as Exhibit 5.1 by Thompson Hine LLP
• ·Sales Agreement originally dated May 25, 2022, with Amendment No. 1 dated May 15, 2024

23-03-2026

Radian Group Inc. disclosed via Regulation FD that the Society of Lloyd’s posted the UK GAAP annual accounts for Syndicate 1301 (managed by Inigo Limited, which Radian acquired on February 2, 2026) for the year ended December 31, 2025, available on Radian's investor relations website. These standalone syndicate accounts are not directly comparable to Radian's or Inigo's consolidated US GAAP financials. Radian plans to file audited 2025 consolidated US GAAP financials for Inigo, along with pro forma information for the acquisition, by no later than April 17, 2026.

• ·Syndicate 1301 Accounts link: https://www.radian.com/-/media/650F6F163C0E4CEFAF5B77F14D51263A.ashx?rev=df270b5f-aadf-4d5e-b575-a8219ad54e67
• ·Original acquisition 8-K filed February 3, 2026, to be amended with Items 9.01(a) and (b)

23-03-2026

Intel Corporation (INTC) filed a DEFA14A Definitive Additional Materials on March 23, 2026, as part of its proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing, titled 'a2026noticeaccess.htm', appears to be a notice of internet availability of proxy materials and indicates no filing fee required. No financial metrics, performance data, or other substantive details are provided in the filing header.

• ·Filing categorized as Definitive Additional Materials (not Preliminary Proxy Statement or Soliciting Material).

23-03-2026

On March 18, 2026, Intelligent Bio Solutions Inc. granted time-vesting restricted stock awards of 9,150 shares each to CEO Harry Simeonidis and CFO Spiro Sakiris (vesting after 48 months), plus performance-vesting awards of 21,350 shares each tied to clinical, regulatory, and commercial milestones; non-employee directors received an aggregate 20,000 time-vesting shares (vesting after 12 months), and non-executive employees received 10,500 time-vesting and 24,500 performance-vesting shares. As of March 23, 2026, the company had 2,001,173 shares of common stock outstanding following these grants and warrant exercises. The company also filed a 2026 ATM Supplement enabling up to $3.97M in additional common stock sales under its existing ATM Agreement.

• ·Performance-vesting shares subject to milestones: 30% upon clinical trial achievement (post-1 year), 40% upon FDA regulatory submission (post-1 year), 30% upon commercial supply/sales milestone (post-1 year); unachieved portions forfeit after 10 years.
• ·Awards include dividend rights on unvested shares (paid upon vesting) and are subject to clawback policy.
• ·ATM Agreement originally dated September 18, 2024; Registration Statement effective September 10, 2025 (File No. 333-286489).